Trial intelligence / Profile preview

Phase 2 trial of Qingfeng Ganke granules for postinfectious cough

ChiCTR-TRC-12002297Phase 2Completed

Sponsor
West China Hospital of Sichuan University
Start
Mar 2011
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Qingfeng Ganke in postinfectious cough (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Duration for cough to disappear and Duration for cough to relieve. Started Mar 2011; status: completed.

02

Drugs

Qingfeng Ganke
03

Conditions

postinfectious cough

Beyond the preview

Go deeper on ChiCTR-TRC-12002297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call